Has Sanjay Chavda, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,557 in general payments to Sanjay Chavda, MD across 458 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sanjay Chavda, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sanjay Chavda, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sanjay Chavda, MD

Pulmonary Disease · Hopkinsville, KYNPI 1437124484

Payments from drug & device makers

$13,557in general payments, 2019–2025

Across 458 payments — averaging $29.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim$5K
AstraZeneca$2K
GSK$1K
Jazz Pharmaceuticals Inc.$1K
Actelion Pharmaceuticals US, Inc.$748
Amgen$440
plus $3K from 38 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim	54	$4,825
AstraZeneca	66	$1,612
GSK	73	$1,371
Jazz Pharmaceuticals Inc.	7	$1,147
Actelion Pharmaceuticals US, Inc.	47	$748
Amgen	28	$440
Regeneron Healthcare Solutions, Inc.	24	$428
Sanofi	15	$275
Lilly USA, LLC	14	$238
United Therapeutics Corporation	8	$219
Baxter Healthcare	5	$176
Insulet Corporation	10	$172
Merck	9	$172
Grifols USA, LLC	12	$172
Mallinckrodt Hospital Products Inc.	4	$155
Johnson & Johnson	10	$153
Novo Nordisk	9	$128
Takeda Pharmaceuticals U.S.A., Inc.	6	$124
Shire North American Group Inc	5	$90
Mylan Specialty L.p.	5	$78
Novartis	4	$76
Viatris Specialty LLC	4	$69
Bayer	5	$68
Genentech USA, Inc.	2	$55
AbbVie(2 entities)	3	$51
Dexcom, Inc.	3	$50
Medtronic	1	$50
Amarin Pharma, Inc.	3	$49
Verona Pharma, Inc.	3	$45
ANI Pharmaceuticals, Inc.	2	$39
Pulmonx Corporation	1	$38
Sunovion Pharmaceuticals Inc.	2	$28
Teva Pharmaceuticals USA, Inc.	2	$26
Pfizer	2	$25
CSL Behring	1	$24
Si-bone, Inc.	1	$21
Xeris Pharmaceuticals, Inc.	1	$20
Gilead	1	$16
Philips North America LLC	1	$15
Advanced Respiratory, Inc	1	$15
Inspire Medical Systems, Inc.	1	$14
Idorsia Pharmaceuticals US Inc	1	$14
Axsome Therapeutics, Inc.	1	$14
Paratek Pharmaceuticals, Inc.	1	$13

How this compares

$13,557 in reported general payments places this provider in the 75th percentile of 226 pulmonary disease providers in Kentucky.

See all pulmonary disease providers in Kentucky →

Medicare billing

Part B allowed, 2024

$11,797

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Hopkinsville

Manoj MajmudarHopkinsville$17K
John McConnellLouisville$3.5M
Girish NairLexington$852K
Sally SulimanLouisville$472K
Mohamed SaadLouisville$440K
David WinslowLouisville$431K
Firas KouraGeorgetown$423K
Erica GregonisRichmond$390K
Karim El-KershLouisville$379K
Harold HallerLouisville$369K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →